The successful induction of G6Pase functional activity in HLCs, with respect to untreated control cells, could open new ways to the use of these cells for treating this genetic disorder currently managed by the evaluation of clinical, laboratory, and imaging data, together with a sole dietary intervention [81]. This evidence concerns the gene G6PC1 and hereditary disease.